Global and United States Prostate Cancer Drugs Market Report & Forecast 2022-2028

Global and United States Prostate Cancer Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Global Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.4 Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Prostate Cancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Prostate Cancer Drugs Market Dynamics
1.5.1 Prostate Cancer Drugs Industry Trends
1.5.2 Prostate Cancer Drugs Market Drivers
1.5.3 Prostate Cancer Drugs Market Challenges
1.5.4 Prostate Cancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Prostate Cancer Drugs Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Chemotherapy
2.1.3 Immunotherapy
2.1.4 Targeted Therapy
2.2 Global Prostate Cancer Drugs Market Size by Type
2.2.1 Global Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Prostate Cancer Drugs Market Size by Type
2.3.1 United States Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Prostate Cancer Drugs Market Segment by Application
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Prostate Cancer Drugs Market Size by Application
3.2.1 Global Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Prostate Cancer Drugs Market Size by Application
3.3.1 United States Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prostate Cancer Drugs Competitor Landscape by Company
4.1 Global Prostate Cancer Drugs Market Size by Company
4.1.1 Top Global Prostate Cancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Prostate Cancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Prostate Cancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Prostate Cancer Drugs Concentration Ratio (CR)
4.2.1 Prostate Cancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prostate Cancer Drugs in 2021
4.2.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Prostate Cancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Prostate Cancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Prostate Cancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Drugs Market Size by Company
4.5.1 Top Prostate Cancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Prostate Cancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Drugs Market Size by Region
5.1 Global Prostate Cancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Prostate Cancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Prostate Cancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Prostate Cancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Prostate Cancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Prostate Cancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Corporation Information
7.1.2 AbbVie Description and Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AbbVie Prostate Cancer Drugs Products Offered
7.1.5 AbbVie Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporation Information
7.2.2 Astellas Pharma Description and Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
7.2.5 Astellas Pharma Recent Development
7.3 Astra Zeneca
7.3.1 Astra Zeneca Corporation Information
7.3.2 Astra Zeneca Description and Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
7.3.5 Astra Zeneca Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Prostate Cancer Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Merck Group
7.7.1 Merck Group Corporation Information
7.7.2 Merck Group Description and Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Merck Group Prostate Cancer Drugs Products Offered
7.7.5 Merck Group Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Prostate Cancer Drugs Products Offered
7.8.5 Novartis Recent Development
7.9 Amgen
7.9.1 Amgen Corporation Information
7.9.2 Amgen Description and Business Overview
7.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Amgen Prostate Cancer Drugs Products Offered
7.9.5 Amgen Recent Development
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Corporation Information
7.10.2 Bayer HealthCare Description and Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
7.10.5 Bayer HealthCare Recent Development
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Corporation Information
7.11.2 Ferring Pharmaceutical Description and Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Products Offered
7.11.5 Ferring Pharmaceutical Recent Development
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Corporation Information
7.12.2 Janssen Pharmaceuticals Description and Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Janssen Pharmaceuticals Products Offered
7.12.5 Janssen Pharmaceuticals Recent Development
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporation Information
7.13.2 Endo Pharmaceuticals Description and Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Endo Pharmaceuticals Products Offered
7.13.5 Endo Pharmaceuticals Recent Development
7.14 BMS
7.14.1 BMS Corporation Information
7.14.2 BMS Description and Business Overview
7.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 BMS Products Offered
7.14.5 BMS Recent Development
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Corporation Information
7.15.2 Takeda Pharmaceuticals Description and Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Takeda Pharmaceuticals Products Offered
7.15.5 Takeda Pharmaceuticals Recent Development
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Corporation Information
7.16.2 Northwest Biotherapeutics Description and Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Northwest Biotherapeutics Products Offered
7.16.5 Northwest Biotherapeutics Recent Development
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Corporation Information
7.17.2 Teva Pharmaceutical Description and Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Teva Pharmaceutical Products Offered
7.17.5 Teva Pharmaceutical Recent Development
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Corporation Information
7.18.2 Boehringer Ingelheim Description and Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Boehringer Ingelheim Products Offered
7.18.5 Boehringer Ingelheim Recent Development
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Corporation Information
7.19.2 Foresee Pharmaceuticals Description and Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Foresee Pharmaceuticals Products Offered
7.19.5 Foresee Pharmaceuticals Recent Development
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Corporation Information
7.20.2 Tokai Pharmaceuticals Description and Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Tokai Pharmaceuticals Products Offered
7.20.5 Tokai Pharmaceuticals Recent Development
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Corporation Information
7.21.2 Spectrum Pharmaceuticals Description and Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Spectrum Pharmaceuticals Products Offered
7.21.5 Spectrum Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Prostate Cancer Drugs Industry Chain Analysis
8.2 Prostate Cancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Prostate Cancer Drugs Distributors
8.3 Prostate Cancer Drugs Production Mode & Process
8.4 Prostate Cancer Drugs Sales and Marketing
8.4.1 Prostate Cancer Drugs Sales Channels
8.4.2 Prostate Cancer Drugs Distributors
8.5 Prostate Cancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Prostate Cancer Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Prostate Cancer Drugs Market Trends
Table 3. Prostate Cancer Drugs Market Drivers
Table 4. Prostate Cancer Drugs Market Challenges
Table 5. Prostate Cancer Drugs Market Restraints
Table 6. Global Prostate Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Prostate Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Prostate Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Prostate Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Prostate Cancer Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Prostate Cancer Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Prostate Cancer Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Prostate Cancer Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Prostate Cancer Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Prostate Cancer Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2021)
Table 18. Top Players of Prostate Cancer Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Prostate Cancer Drugs Product Type
Table 20. Date of International Manufacturers Enter into Prostate Cancer Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Prostate Cancer Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Prostate Cancer Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Prostate Cancer Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Prostate Cancer Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Prostate Cancer Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Prostate Cancer Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Prostate Cancer Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Prostate Cancer Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Prostate Cancer Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Prostate Cancer Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Prostate Cancer Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. AbbVie Corporation Information
Table 43. AbbVie Description and Business Overview
Table 44. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. AbbVie Prostate Cancer Drugs Product
Table 46. AbbVie Recent Development
Table 47. Astellas Pharma Corporation Information
Table 48. Astellas Pharma Description and Business Overview
Table 49. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Astellas Pharma Product
Table 51. Astellas Pharma Recent Development
Table 52. Astra Zeneca Corporation Information
Table 53. Astra Zeneca Description and Business Overview
Table 54. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Astra Zeneca Product
Table 56. Astra Zeneca Recent Development
Table 57. Johnson & Johnson Corporation Information
Table 58. Johnson & Johnson Description and Business Overview
Table 59. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson Product
Table 61. Johnson & Johnson Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. GlaxoSmithKline Corporation Information
Table 68. GlaxoSmithKline Description and Business Overview
Table 69. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. GlaxoSmithKline Product
Table 71. GlaxoSmithKline Recent Development
Table 72. Merck Group Corporation Information
Table 73. Merck Group Description and Business Overview
Table 74. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Merck Group Product
Table 76. Merck Group Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Amgen Corporation Information
Table 83. Amgen Description and Business Overview
Table 84. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Amgen Product
Table 86. Amgen Recent Development
Table 87. Bayer HealthCare Corporation Information
Table 88. Bayer HealthCare Description and Business Overview
Table 89. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Bayer HealthCare Product
Table 91. Bayer HealthCare Recent Development
Table 92. Ferring Pharmaceutical Corporation Information
Table 93. Ferring Pharmaceutical Description and Business Overview
Table 94. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Ferring Pharmaceutical Product
Table 96. Ferring Pharmaceutical Recent Development
Table 97. Janssen Pharmaceuticals Corporation Information
Table 98. Janssen Pharmaceuticals Description and Business Overview
Table 99. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Janssen Pharmaceuticals Product
Table 101. Janssen Pharmaceuticals Recent Development
Table 102. Endo Pharmaceuticals Corporation Information
Table 103. Endo Pharmaceuticals Description and Business Overview
Table 104. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Endo Pharmaceuticals Product
Table 106. Endo Pharmaceuticals Recent Development
Table 107. BMS Corporation Information
Table 108. BMS Description and Business Overview
Table 109. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. BMS Product
Table 111. BMS Recent Development
Table 112. Takeda Pharmaceuticals Corporation Information
Table 113. Takeda Pharmaceuticals Description and Business Overview
Table 114. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Takeda Pharmaceuticals Product
Table 116. Takeda Pharmaceuticals Recent Development
Table 117. Northwest Biotherapeutics Corporation Information
Table 118. Northwest Biotherapeutics Description and Business Overview
Table 119. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Northwest Biotherapeutics Product
Table 121. Northwest Biotherapeutics Recent Development
Table 122. Teva Pharmaceutical Corporation Information
Table 123. Teva Pharmaceutical Description and Business Overview
Table 124. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Teva Pharmaceutical Product
Table 126. Teva Pharmaceutical Recent Development
Table 127. Boehringer Ingelheim Corporation Information
Table 128. Boehringer Ingelheim Description and Business Overview
Table 129. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Boehringer Ingelheim Product
Table 131. Boehringer Ingelheim Recent Development
Table 132. Foresee Pharmaceuticals Corporation Information
Table 133. Foresee Pharmaceuticals Description and Business Overview
Table 134. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Foresee Pharmaceuticals Product
Table 136. Foresee Pharmaceuticals Recent Development
Table 137. Tokai Pharmaceuticals Corporation Information
Table 138. Tokai Pharmaceuticals Description and Business Overview
Table 139. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Tokai Pharmaceuticals Product
Table 141. Tokai Pharmaceuticals Recent Development
Table 142. Spectrum Pharmaceuticals Corporation Information
Table 143. Spectrum Pharmaceuticals Description and Business Overview
Table 144. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Spectrum Pharmaceuticals Product
Table 146. Spectrum Pharmaceuticals Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Prostate Cancer Drugs Customers List
Table 150. Prostate Cancer Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Global Prostate Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Prostate Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Prostate Cancer Drugs Sales 2017-2028 (K MT)
Figure 5. United States Prostate Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Prostate Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Prostate Cancer Drugs Sales 2017-2028 (K MT)
Figure 8. United States Prostate Cancer Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Prostate Cancer Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Prostate Cancer Drugs Report Years Considered
Figure 11. Product Picture of Hormonal Therapy
Figure 12. Product Picture of Chemotherapy
Figure 13. Product Picture of Immunotherapy
Figure 14. Product Picture of Targeted Therapy
Figure 15. Global Prostate Cancer Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Prostate Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Prostate Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 19. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Prostate Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Prostate Cancer Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Prostate Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Prostate Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Prostate Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 25. United States Prostate Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Prostate Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Hospitals
Figure 29. Product Picture of Others
Figure 30. Global Prostate Cancer Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Prostate Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Prostate Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 34. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Prostate Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 36. United States Prostate Cancer Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Prostate Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Prostate Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Prostate Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 40. United States Prostate Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Prostate Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. China Taiwan Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs